Plasma Market Dynamics & COVID19 Impact
Immunoglobulin has become ever more dominant in terms of
plasma economics for the entire industry.
1.
2.
3.
4.
IG is the global plasma market driver since the 1990s. The IG manufacturers base their plasma
collections on their immunoglobulin sales forecasts.
Albumin is also a last liter product today.
5.
6.
7.
Since both products are made from practically every liter of plasma fractionated, the only way
to increase (or decrease) the supply is to collect and fractionate more (or less) plasma.
Albumin demand growth has been slower than plasma collections (and thus supply), resulting
in flat to declining prices
IG demand growth has been among the fastest compared to all plasma proteins
As a result, companies have collected plasma to meet the expected IG demand in the 2010s,
with growth at rates averaging 8-9% per year.
But then.....
COVID19 Pandemic happened, severely affecting plasma collections
7
(MRB)View entire presentation